knowledge -WSS

knowledge

author：fashion 2025-10-02 00:53:13 - browse：59318

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： New Ultima Genomics DNA sequencer can read genome for $100

WSS

Inaction leaves children at risk from dangerous chemotherapy drug

Cybersecurity threat forces Lurie Children's to take systems offline

Dana Farber says 6 studies to be retracted and 31 corrected

Medicare drug price lawsuits could be good politics for Biden

There's an unseen cost to disruptive road

Even great ERs can’t make up for American health disparities

explore

knowledge

focus

The high cost of giving birth even with insurance

Vertex non

Wildfire smoke exposes gaps in outdoor worker protections

Apple Vision Pro: A first look at health apps on the new VR headset

As demand for Covid shots wanes, Moderna seeks its next success

Dana Farber says 6 studies to be retracted and 31 corrected

The high cost of giving birth even with insurance

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

New air purifier tech could be key to improving indoor air quality

FDA endorses new sterilization method for medical devices

leisure time

ARCH Venture Partners is raising $3 billion for a life sciences fund

Immunocompromised patients offer clues on chronic Covid

ARCH Venture Partners is raising $3 billion for a life sciences fund

Biden administration opens offers in Medicare drug price negotiations

Biden administration opens offers in Medicare drug price negotiations

A $475,000 price tag for a new cancer drug: crazy or meh?

hotspot

focus

entertainment

Wikipedia